HK1208157A1 - Formulations involving solvent/detergent-treated plasma (s/d plasma) and uses thereof /(s/d ) - Google Patents
Formulations involving solvent/detergent-treated plasma (s/d plasma) and uses thereof /(s/d )Info
- Publication number
- HK1208157A1 HK1208157A1 HK15108763.1A HK15108763A HK1208157A1 HK 1208157 A1 HK1208157 A1 HK 1208157A1 HK 15108763 A HK15108763 A HK 15108763A HK 1208157 A1 HK1208157 A1 HK 1208157A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- plasma
- detergent
- formulations involving
- treated
- involving solvent
- Prior art date
Links
- 239000003599 detergent Substances 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000002904 solvent Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1841—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2053—IL-8
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Polymers & Plastics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Botany (AREA)
- Neurology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12186027 | 2012-09-26 | ||
PCT/EP2013/070085 WO2014049063A1 (en) | 2012-09-26 | 2013-09-26 | Formulations involving solvent/detergent-treated plasma (s/d plasma) and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1208157A1 true HK1208157A1 (en) | 2016-02-26 |
Family
ID=46963571
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15108763.1A HK1208157A1 (en) | 2012-09-26 | 2015-09-09 | Formulations involving solvent/detergent-treated plasma (s/d plasma) and uses thereof /(s/d ) |
Country Status (17)
Country | Link |
---|---|
US (1) | US11458166B2 (ja) |
EP (1) | EP2900247B1 (ja) |
JP (4) | JP2015532919A (ja) |
KR (1) | KR101848830B1 (ja) |
CN (2) | CN104703612B (ja) |
AU (1) | AU2013322604B2 (ja) |
BE (1) | BE1021755B1 (ja) |
CA (1) | CA2882317C (ja) |
DK (1) | DK2900247T3 (ja) |
ES (1) | ES2664694T3 (ja) |
HK (1) | HK1208157A1 (ja) |
IL (1) | IL237757B (ja) |
NO (1) | NO2900247T3 (ja) |
PL (1) | PL2900247T3 (ja) |
PT (1) | PT2900247T (ja) |
SG (1) | SG11201502402VA (ja) |
WO (1) | WO2014049063A1 (ja) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016170112A1 (en) | 2015-04-23 | 2016-10-27 | Bone Therapeutics S.A. | In vitro preservation of therapeutic cells |
NZ747413A (en) * | 2016-04-27 | 2020-09-25 | Anika Therapeutics Inc | Compositions for use in treating tendon degeneration |
CN107789647B (zh) * | 2016-09-05 | 2021-02-02 | 上海赛伦生物技术股份有限公司 | 一种灭活动物血清或血浆中病毒的方法 |
JP2022502034A (ja) * | 2018-09-25 | 2022-01-11 | ボーン、セラピューティクス、エスアーBone Thrapeutics Sa | in vitro分化細胞の骨形成能を決定するための方法および使用 |
KR102207694B1 (ko) * | 2019-01-11 | 2021-01-26 | 서울대학교산학협력단 | 내재성 세포를 이용한 근골격계 손상과 질환 예방 또는 치료용 약학 조성물 |
WO2020229526A1 (en) | 2019-05-13 | 2020-11-19 | Bone Therapeutics Sa | Improved lyophilized formulations involving hyaluronic acid and plasmatic proteins, and uses thereof |
AU2020311591A1 (en) | 2019-07-08 | 2022-02-03 | Theravet Sa | A method for the preparation of a gel-forming composition |
JP2022539467A (ja) | 2019-07-08 | 2022-09-09 | セラヴェット ソシエテ アノニム | 組成物、キットおよびその使用 |
US20220249553A1 (en) | 2019-07-08 | 2022-08-11 | Theravet Sa | A composition, a kit and use thereof |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4764369A (en) * | 1983-07-14 | 1988-08-16 | New York Blood Center Inc. | Undenatured virus-free biologically active protein derivatives |
US4909940A (en) * | 1987-12-30 | 1990-03-20 | New York Blood Center, Inc. | Extraction of process chemicals from labile biological mixtures with organic alcohols or with halogenated hydrocarbons |
US5811094A (en) | 1990-11-16 | 1998-09-22 | Osiris Therapeutics, Inc. | Connective tissue regeneration using human mesenchymal stem cell preparations |
US5486359A (en) | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
US5837539A (en) | 1990-11-16 | 1998-11-17 | Osiris Therapeutics, Inc. | Monoclonal antibodies for human mesenchymal stem cells |
US5972703A (en) | 1994-08-12 | 1999-10-26 | The Regents Of The University Of Michigan | Bone precursor cells: compositions and methods |
US20020018777A1 (en) | 1995-01-05 | 2002-02-14 | Alfred M. Prince | Sterilization of virus infected plasma |
US5736396A (en) | 1995-01-24 | 1998-04-07 | Case Western Reserve University | Lineage-directed induction of human mesenchymal stem cell differentiation |
US5827740A (en) | 1996-07-30 | 1998-10-27 | Osiris Therapeutics, Inc. | Adipogenic differentiation of human mesenchymal stem cells |
US5981254A (en) * | 1997-10-30 | 1999-11-09 | Haemacure Corporation | Process for producing thrombin from plasma |
WO2000007639A1 (en) | 1998-08-07 | 2000-02-17 | Tissue Engineering, Inc. | Bone precursor compositions |
CA2385179A1 (en) | 1999-10-08 | 2001-04-19 | David J. Hammond | Isoagglutinin-depleted blood compositions and methods of making same |
MXPA03000203A (es) * | 2000-06-29 | 2004-09-13 | Biosyntech Canada Inc | Composicion y metodo para la reparacion y regeneracion del cartilago y otros tejidos. |
IL144446A0 (en) | 2001-07-19 | 2002-05-23 | Prochon Biotech Ltd | Plasma protein matrices and methods for their preparation |
MXPA01011542A (es) * | 2001-11-13 | 2003-05-22 | Alcon Inc | Regeneracion del cartilago articular da°ado por la osteoartritis de grado i y ii, mediante la aplicacion intra-articular de una mezcla de hialuronato de sodio y de condroitin sulfato en un vehiculo de gel. |
CN101005859B (zh) | 2004-06-29 | 2012-08-15 | 利莱恩斯生命科学有限公司 | 灭病毒生物液体的制备方法 |
DE102004044429B4 (de) * | 2004-09-14 | 2009-04-30 | Biotest Ag | Verfahren zur Herstellung einer Zusammensetzung enthaltend von Willebrand Faktor |
ITPD20050056A1 (it) * | 2005-03-02 | 2006-09-03 | Fidia Farmaceutici | Derivati ammidici del'acido ialuronico in osteoartrosi |
KR20070113876A (ko) * | 2006-05-26 | 2007-11-29 | 메디제네스(주) | 혈장성분을 함유하는 창상 치료용 약학 조성물 |
ES2333498B1 (es) | 2007-08-02 | 2011-01-10 | Biotechnology Institute, I Mas D, S.L. | Metodo y compuesto para el tratamiento de enfermedades o dolencias articulares o para el tratamiento de la piel con fines esteticos u otros, y el metodo de preparacion del compuesto. |
US20090264477A1 (en) * | 2008-04-18 | 2009-10-22 | Warsaw Orthopedic, Inc., An Indiana Corporation | Beta adrenergic receptor agonists for treatment of pain and/or inflammation |
AT514675B1 (de) * | 2009-07-23 | 2019-05-15 | Baxalta Inc | Herstellung von faktor h (fh) und fh-derivaten aus plasma |
ES2578478T3 (es) * | 2009-09-17 | 2016-07-27 | Baxalta Incorporated | Coformulación estable de hialuronidasa e inmunoglobulina, y métodos de uso de la misma |
JP5737860B2 (ja) | 2010-04-30 | 2015-06-17 | テルモ株式会社 | ゲル状細胞組成物およびその製造方法 |
IL210162A0 (en) | 2010-12-21 | 2011-03-31 | Omrix Biopharmaceuticals | Viral inactivated platelet extract, use and preparation thereof |
US20120171182A1 (en) | 2010-12-31 | 2012-07-05 | Jae Woo Pak | Methods and compositions for the treatment, prevention, and alleviation of bone and cartilage diseases or injuries and hair loss |
US20120171169A1 (en) * | 2010-12-31 | 2012-07-05 | Jaewoo Pak | Compositions and methods for treating, preventing, or alleviating bone or cartilage diseases |
KR101038616B1 (ko) | 2011-03-16 | 2011-06-03 | 박재우 | 뼈 및 연골 질환의 치료, 예방, 또는 완화용 약제학적 조성물 |
-
2013
- 2013-09-26 AU AU2013322604A patent/AU2013322604B2/en active Active
- 2013-09-26 BE BE2013/0645A patent/BE1021755B1/fr active
- 2013-09-26 DK DK13780080.1T patent/DK2900247T3/en active
- 2013-09-26 PL PL13780080T patent/PL2900247T3/pl unknown
- 2013-09-26 NO NO13780080A patent/NO2900247T3/no unknown
- 2013-09-26 US US14/431,720 patent/US11458166B2/en active Active
- 2013-09-26 SG SG11201502402VA patent/SG11201502402VA/en unknown
- 2013-09-26 ES ES13780080.1T patent/ES2664694T3/es active Active
- 2013-09-26 CA CA2882317A patent/CA2882317C/en active Active
- 2013-09-26 EP EP13780080.1A patent/EP2900247B1/en active Active
- 2013-09-26 CN CN201380050163.4A patent/CN104703612B/zh active Active
- 2013-09-26 WO PCT/EP2013/070085 patent/WO2014049063A1/en active Application Filing
- 2013-09-26 PT PT137800801T patent/PT2900247T/pt unknown
- 2013-09-26 JP JP2015532472A patent/JP2015532919A/ja active Pending
- 2013-09-26 CN CN202110267878.1A patent/CN112999245A/zh active Pending
- 2013-09-26 KR KR1020157010195A patent/KR101848830B1/ko active IP Right Grant
-
2015
- 2015-03-16 IL IL237757A patent/IL237757B/en active IP Right Grant
- 2015-09-09 HK HK15108763.1A patent/HK1208157A1/xx unknown
-
2018
- 2018-07-06 JP JP2018129470A patent/JP2018184425A/ja active Pending
-
2019
- 2019-11-07 JP JP2019202677A patent/JP2020050659A/ja active Pending
-
2022
- 2022-01-04 JP JP2022000211A patent/JP2022061997A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP2900247A1 (en) | 2015-08-05 |
CA2882317A1 (en) | 2014-04-03 |
CN104703612A (zh) | 2015-06-10 |
CA2882317C (en) | 2021-04-06 |
JP2018184425A (ja) | 2018-11-22 |
AU2013322604B2 (en) | 2018-01-18 |
US20150238528A1 (en) | 2015-08-27 |
NO2900247T3 (ja) | 2018-06-16 |
DK2900247T3 (en) | 2018-03-05 |
PL2900247T3 (pl) | 2018-05-30 |
ES2664694T3 (es) | 2018-04-23 |
CN112999245A (zh) | 2021-06-22 |
CN104703612B (zh) | 2021-03-19 |
PT2900247T (pt) | 2018-03-28 |
KR20150067209A (ko) | 2015-06-17 |
JP2015532919A (ja) | 2015-11-16 |
JP2020050659A (ja) | 2020-04-02 |
KR101848830B1 (ko) | 2018-04-16 |
AU2013322604A1 (en) | 2015-04-02 |
EP2900247B1 (en) | 2018-01-17 |
WO2014049063A1 (en) | 2014-04-03 |
BE1021755B1 (fr) | 2016-01-15 |
SG11201502402VA (en) | 2015-05-28 |
US11458166B2 (en) | 2022-10-04 |
IL237757B (en) | 2018-10-31 |
JP2022061997A (ja) | 2022-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL262600B (en) | Vectors and their medical uses | |
HK1208157A1 (en) | Formulations involving solvent/detergent-treated plasma (s/d plasma) and uses thereof /(s/d ) | |
HK1211206A1 (en) | Virus-containing formulation and use thereof | |
HK1203812A1 (en) | Novel pharmaceutical formulations | |
HK1209636A1 (en) | Trans-clomiphene formulations and uses thereof (trans-clomiphene) | |
IL251974A0 (en) | Antifibrosis compounds and their uses | |
EP2918665A4 (en) | SOLVENT COMPOSITION | |
SG11201500111VA (en) | Peptides and uses thereof | |
EP2964371A4 (en) | SOLVENT FORMULATIONS | |
HK1209337A1 (en) | Medicament-containing hollow particle | |
HK1205146A1 (en) | Pharmaceutical formulation | |
EP2807256A4 (en) | MYONECTIN (CTRP15), COMPOSITION COMPRISING SAME AND METHODS OF USE | |
GB2508400B (en) | Gyroscopic system | |
ZA201501601B (en) | Virus purification and formulation process | |
EP2822599A4 (en) | VACCINE | |
GB201215184D0 (en) | Therapeutic virus | |
HK1209339A1 (en) | Pharmaceutical formulations | |
GB201217908D0 (en) | Retractable footrest | |
AU2012901774A0 (en) | Vaccine and uses thereof | |
IL238527A0 (en) | System and methods for cross-rib transfer | |
GB2502895B (en) | Trouser Braces and Adaptor | |
AU2013100951A4 (en) | Improved Scaffold | |
AU341417S (en) | Telescoping dolly | |
GB201211403D0 (en) | Pharmaceutical formulations | |
GB201211406D0 (en) | Pharmaceutical formulations |